Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pseudomyxoma Peritonei 1Pain, Postoperative 1Neoplasms 1Breast Neoplasms 1

Interventions

Mitomycin 3Hyperthermic Intraperitoneal Chemotherapy 3Surveys and Questionnaires 2Fluorouracil 2Capecitabine 2tislelizumab 1molgramostim 1irinotecan sucrosofate 1Tacrolimus 1Standard of Care 1Sirolimus 1Referral and Consultation 1Radiosurgery 1Psychiatric Rehabilitation 1Pharmacogenomic Testing 1Oxaliplatin 1Observation 1Methods 1Leucovorin 1Lansoprazole 1Ifosfamide 1Gemcitabine 1Early Intervention, Educational 1Doxorubicin 1Cytoreduction Surgical Procedures 1Clarithromycin 1Cisplatin 1Carboplatin 1Bromelains 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pseudomyxoma Peritonei × Bromelains × Clear all
NCT04982146 2022-06-02

Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei

Maimónides Biomedical Research Institute of Córdoba

Phase 1 Unknown
10 enrolled

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡